✦ LIBER ✦

mitoNEET as a novel drug target for mitochondrial dysfunction

✍ Scribed by Geldenhuys, Werner J.; Leeper, Thomas C.; Carroll, Richard T.

Book ID: 121826264
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 675 KB
Volume: 19
Category: Article
ISSN: 1359-6446
DOI: 10.1016/j.drudis.2014.05.001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Claudin as a Novel Target for Drug Deliv

Claudin as a Novel Target for Drug Delivery System

✍ Masuo Kondoh 📂 Article 📅 2007 🏛 John Wiley and Sons ⚖ 18 KB 👁 2 views

MicroRNA as a novel drug target for canc

MicroRNA as a novel drug target for cancer therapy

✍ Liu, Xiaoxia; Liu, Li; Xu, Qian; Wu, Ping; Zuo, Xialin; Ji, Aimin 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 216 KB

Mitochondrial Dysfunction as a Therapeut

Mitochondrial Dysfunction as a Therapeutic Target in Progressive Supranuclear Palsy

✍ Vincent Ries; Wolfgang H. Oertel; Günter U. Höglinger 📂 Article 📅 2011 🏛 Humana Press Inc 🌐 English ⚖ 125 KB

GABA A receptors as targets for novel an

GABA A receptors as targets for novel anxiolytic drugs

✍ Rupprecht, Rainer; Eser, Daniela; Zwanzger, Peter; Möller, Hans-Jürgen 📂 Article 📅 2006 🏛 Informa plc 🌐 English ⚖ 266 KB

BMI1 as a novel target for drug discover

BMI1 as a novel target for drug discovery in cancer

✍ Liangxian Cao; Jenelle Bombard; Katherine Cintron; Josephine Sheedy; Marla L. We 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 889 KB

Growing evidence has demonstrated that clonogenic cancer stem (initiating) cells are responsible for tumor regrowth and disease relapse. Bmi-1 plays a critical role in the self-renewal of adult stem cells. The Bmi-1 protein is elevated in many types of cancers, and experimental reduction of Bmi-1 pr

THE MGLU2 RECEPTOR AS A NOVEL DRUG TARGE

THE MGLU2 RECEPTOR AS A NOVEL DRUG TARGET FOR SCHIZOPHRENIA

✍ Kjell Svensson 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 63 KB